Why Do Biotechs Love the IRS Today? Washington Companies Just Got $34M in Grants

Luke Timmerman11/2/10Follow @ldtimmerman

Share and Comment

Leave a Comment Order a Reprint E-mail this Story

• Share on Twitter
• Share on Facebook


• Share on Linkedin
• Share on Google
• Submit to Hacker News

(Page 2 of 4)

Anergix $244,479

AVI Biopharma $1,222,395

Blood Cell Storage $488,958

Calistoga Pharmaceuticals $733,437

Calypso Medical Technologies $488,958

Cancer Targeted Technology $183,928

Cell Therapeutics $977,916

Cerevast Therapeutics $244,479

CG Therapeutics $244,479

CoCrystal Discovery $733,435

Columbia Northwest Pharmaceuticals $488,958

Ekos $297,683

Emergent Detection $229,900

Enject $244,479

Epigenomics $244,479

Etubics $244,479

Focused Scientific $23,232

Healionics $244,479

HemaQuest Pharmaceuticals $977,916

Hyprotek $244,479

Immune Design $488,958

Impel Neuropharma $244,479

Implicit Bioscience $244,479

Inimex Pharmaceuticals $244,479

Insilicos $244,479

Integrated Diagnostics $733,435 … Next Page »

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @ldtimmerman